MCT1 overexpression in breast cancer is correlated with ER negativity, PR negativity, high Ki-67 labeling index (Li et al., 2018), basal-like type (Pinheiro et al., 2010), high grade, high stage, increased recurrence, and poor prognosis (Johnson et al., 2017). This evidence concerns the gene PGR and breast carcinoma.